PSG or HSAT? Choosing the Right Test

Opening Clinical Case

A 47-year-old man with obesity, chronic opioid use, severe insomnia, morning headaches, and daytime hypoxemia is referred for an HSAT because it is “faster.” The result returns with a low respiratory event index, and the referral note seems to breathe a sigh of relief. Unfortunately, the test never actually answered the clinical question. It could not tell you whether the patient had sleep-related hypoventilation, central apnea, major sleep fragmentation from insomnia, or another sleep disorder requiring a more complete study. In other words, the wrong test produced a confident-looking number that was not especially useful.

That is the central lesson of this chapter: choose the test that can answer the real question, not the test that is merely convenient. In sleep medicine, convenience is nice; physiologic accuracy is nicer.

What You Should Be Able to Do After This Chapter

By the end of this chapter, you should be able to:

• Define the clinical question before ordering PSG or HSAT.

• Identify when HSAT is appropriate and when PSG is preferred.

• Recognize why HSAT can underestimate sleep-disordered breathing severity.

• Understand when CO₂ monitoring is needed.

• Interpret a negative or technically inadequate HSAT correctly.

• Decide when a split-night study is reasonable and when it is not.

• Avoid common ordering errors in medically complicated patients.

The Core Concept

Start with the clinical question. Are you looking for uncomplicated OSA, or could the patient have central apnea, hypoventilation, another sleep disorder, or a medically complicated presentation that needs a richer physiologic picture? If you do not define the question, you may order a test that can only answer the easy part and miss the reason the patient came in the first place.

Medical explanation: PSG is a full physiologic sleep study that can assess sleep stage, arousals, respiratory effort, oxygenation, body position, limb movements, and, when needed, carbon dioxide. HSAT is a focused test designed for selected adults with suspected uncomplicated OSA, and it is inherently less comprehensive.pmc.ncbi.nlm.nih+1 Explain It Like I’m 10: do not choose a test because it is convenient. Choose the test because it can actually see the thing you are looking for. Back to clinical medicine: the diagnostic strategy should follow the suspected mechanism. If the story is complicated, use the test that can read the whole story.

A clinical decision map makes the logic explicit.

What PSG Can Provide

PSG is the full camera crew. It records sleep stage, arousals, airflow, respiratory effort, oxygenation, heart rhythm, body position, and often limb movements; additional channels can be added when clinically appropriate, including carbon-dioxide monitoring. That breadth is exactly why PSG is valuable when the differential is broader than uncomplicated OSA. It tells you whether the patient was actually asleep, what stage they were in, how they breathed, whether arousals were frequent, and whether there were clues to another disorder sitting quietly in the background.pmc.ncbi.nlm.nih+1

PSG is particularly helpful when you need to distinguish obstructive from central events, evaluate sleep fragmentation, assess REM- or position-specific disease, or investigate suspected hypoventilation. It is also the better study when the patient’s symptoms could reflect insomnia, periodic limb movements, parasomnia, or another sleep disorder not captured by a respiratory-only test. PSG does more work because it is designed to do more work.

Explain It Like I’m 10: PSG watches several systems at once and knows whether the patient is actually asleep. Back to clinical medicine: when the question is physiologically broad, PSG is usually the more appropriate tool.

Why sleep staging matters

Sleep staging can explain why the patient’s symptoms are disproportionate to a simple event index, because REM clustering, arousal burden, and sleep fragmentation may drive the clinical picture. Without staging, you may know that the patient spent the night being monitored, but you may not know whether the relevant sleep architecture was even captured. That can be especially important in insomnia, REM-predominant disease, and complicated cardiopulmonary or neurologic cases.

What HSAT Can Provide

HSAT is a smaller camera crew. In selected uncomplicated adults with a high suspicion of moderate-to-severe OSA, it can capture focused respiratory signals and oxygenation and may estimate effort or peripheral arterial tone depending on device design. It is useful when the question is narrow and the patient is uncomplicated. It is not designed to answer every sleep question, and it cannot reliably replace PSG when the physiology is complicated.pmc.ncbi.nlm.nih+1

HSAT typically uses monitoring time rather than true sleep time, which can underestimate event frequency, especially in patients who are awake for large portions of the recording. That limitation matters a lot in severe insomnia, where the denominator becomes messy fast. HSAT also has technical failure risk, signal loss, and reduced ability to detect central events, arousals, sleep staging, and hypoventilation. The device is not “bad”; it is simply not built for every job.

Explain It Like I’m 10: HSAT is a smaller camera crew. It can answer a focused question, but it cannot see everything the lab can see. Back to clinical medicine: HSAT is most appropriate when the patient is an uncomplicated adult with suspected OSA and the equipment, instruction, and interpretation are solid.

Monitoring time versus sleep time

HSAT usually divides events by monitoring time rather than total sleep time, because it cannot stage sleep with the richness of PSG. In patients who are awake for a substantial portion of the night, the resulting respiratory event index can underestimate true severity. That is why a low REI in severe insomnia is not a comforting number; it may simply mean the test was using a denominator that did not reflect actual sleep.

When HSAT May Be Appropriate

HSAT may be appropriate in an adult patient with a high clinical suspicion of moderate-to-severe uncomplicated OSA, provided there are no major complicating conditions and the patient can be instructed properly. That means the patient should not have strong suspicion for hypoventilation, central apnea, another sleep disorder, or significant cardiopulmonary complexity. The device must be technically sound, the setup must be clear, and interpretation must be qualified.pmc.ncbi.nlm.nih+1

HSAT works best when the clinical question is focused: “Does this uncomplicated adult likely have moderate-to-severe OSA?” It works less well when the question becomes “What exactly is causing this complicated breathing complaint?” Those are different questions, and they deserve different tests.

Appropriate HSAT profile

• Adult patient.

• High suspicion for uncomplicated moderate-to-severe OSA.

• No major cardiorespiratory or neurologic complicating condition.

• No strong suspicion for hypoventilation or central apnea.

• Adequate instruction and reliable equipment.

When PSG Is Generally Preferred

PSG is generally preferred when the patient has significant cardiorespiratory disease, potential respiratory muscle weakness, awake hypoventilation or suspected sleep-related hypoventilation, chronic opioid use, history of stroke, severe insomnia, or concern for another sleep disorder. These are exactly the situations where a limited test is most likely to miss the point. If the patient might have central apnea, hypoventilation, major arousal burden, or another disorder entirely, PSG is the better choice.pmc.ncbi.nlm.nih+1

Explain It Like I’m 10: when the breathing story is complicated, use the test that can read the whole story. Back to clinical medicine: the AASM diagnostic guideline supports PSG in these higher-complexity settings because a focused respiratory screen is not enough.pmc.ncbi.nlm.nih+1

Why these conditions matter

Chronic opioid use can depress ventilatory drive and produce central events or hypoventilation. Severe insomnia can reduce the reliability of monitoring-time-based indices. Significant cardiopulmonary disease can create hypoxemia or periodic breathing patterns that HSAT will not characterize well. Stroke, neuromuscular weakness, and suspected hypoventilation all increase the need for staging, effort analysis, and possible CO₂ monitoring.

The Negative or Inconclusive HSAT

A negative HSAT does not automatically mean no disease. It may be technically inadequate, falsely negative, or simply the wrong test for the clinical question. It may also underestimate severity because it uses monitoring time rather than true sleep time and may fail to capture the relevant part of the night. That is why a negative HSAT in a patient with persistent suspicion should usually lead to PSG rather than confidence theater.

Repeating HSAT is not always the best next step. If the original concern includes insomnia, hypoventilation, central apnea, or another sleep disorder, repeating the same limited test may just produce a second incomplete answer with better confidence lighting. The right move after an inconclusive or negative HSAT depends on why the first test was insufficient, but PSG is often the more useful follow-up.

Explain It Like I’m 10: a negative test may mean “no disease,” but it may also mean “the test missed it” or “the test was not built for this problem.” Back to clinical medicine: if suspicion remains high, especially in a complicated patient, a negative HSAT should not close the case.

When PSG should follow

• Persistent clinical suspicion despite negative HSAT.

• Technically inadequate recording.

• Severe insomnia or likely wakefulness during most of the night.

• Suspected hypoventilation or central apnea.

• Major cardiopulmonary or neurologic comorbidity.

Split-Night Studies

A split-night study combines a diagnostic portion and a titration portion in the same night. When successful, it can be efficient and reduce time to treatment. When it fails, it can leave you with insufficient diagnostic sleep time, insufficient titration time, or both. Not every patient is a good split-night candidate, and this is one of those places where the phrase “let’s just squeeze it into one night” can become a little too optimistic.

Split-night studies work best when there is enough early diagnostic data to establish OSA and enough remaining sleep time to titrate therapy meaningfully. They are less useful when the patient has little sleep early in the night, severe insomnia, suspected hypoventilation, or complex respiratory events that require a longer, more nuanced study. If the night is not long enough to answer both questions well, the study becomes a compromise rather than a solution.

Explain It Like I’m 10: one night can sometimes do two jobs, but only if there is enough time for both. Back to clinical medicine: the appeal of efficiency should not outrun the need for interpretable data.

When Carbon-Dioxide Monitoring Matters

Carbon-dioxide monitoring matters when hypoventilation is on the table. That includes suspected obesity hypoventilation syndrome, neuromuscular weakness, chest-wall disorders, medication-related respiratory depression, awake hypoventilation, and sustained unexplained nocturnal desaturation. If the clinical question includes ventilation rather than just obstruction, the study needs a way to assess CO₂, not just oxygen.pmc.ncbi.nlm.nih+1

PSG with transcutaneous or end-tidal CO₂ monitoring can help identify sustained nocturnal hypercapnia, sleep-related worsening of hypoventilation, and patterns that would be invisible to a respiratory-only home test. This is especially important when the patient has obesity, opioid exposure, weakness, or a mismatch between the oxygen tracing and the apparent event burden. A low REI with persistent desaturation should make you suspicious, not relaxed.

Explain It Like I’m 10: if the patient may not be moving enough air, you need a test that can notice carbon dioxide building up. Back to clinical medicine: oxygenation and ventilation are different. You can fix one and still miss the other if you do not monitor CO₂.

CO₂ signals to watch

• Sustained rise across sleep.

• Sleep-related increase from wakefulness.

• REM-related worsening.

• Persistent nocturnal elevation with or without obvious obstructive events.

Diagnostic Reasoning

Before ordering a test, define the mechanism you are trying to detect. If the question is uncomplicated OSA in a high-probability adult without major comorbidity, HSAT may be appropriate. If the question includes central apnea, hypoventilation, insomnia, other sleep disorders, or significant medical complexity, PSG is generally the better choice. The right test is the one that can answer the question without forcing you to infer too much from too little.pmc.ncbi.nlm.nih+1

A practical way to think about it: ask whether you need sleep staging, CO₂ monitoring, arousal analysis, or detection of central events. If yes, you are drifting toward PSG. If no, and the patient is uncomplicated, HSAT may be reasonable. That is not an insurance rule; it is a physiology rule.

Differential diagnosis that pushes you toward PSG

• Central sleep apnea or periodic breathing.

• Sleep-related hypoventilation.

• Severe insomnia.

• Neuromuscular weakness.

• Significant cardiorespiratory disease.

• Another sleep disorder such as parasomnia or limb movement disorder.

Understanding the Relevant Data

The most important thing to understand about PSG versus HSAT is not merely what each one measures, but what each one cannot reliably measure. PSG can stage sleep, quantify arousals, separate obstructive from central events more precisely, and incorporate CO₂ monitoring when needed. HSAT can identify many cases of uncomplicated OSA, but it may underestimate event frequency, miss hypoventilation, and fail to characterize comorbidity or sleep fragmentation.pmc.ncbi.nlm.nih+1

Technical adequacy matters. A technically inadequate HSAT is not a reassuring negative result; it is an incomplete attempt. Night-to-night variability also matters, especially in borderline or phenotype-specific disease. If the first test did not answer the question, the correct response is to obtain the test that can.

Key interpretation table

Management

Management begins with choosing the right diagnostic pathway. If the patient is medically complicated, the cost of a limited test may be a missed diagnosis. If the patient is uncomplicated and the clinical question is narrow, HSAT can be efficient and appropriate. The art is matching the tool to the task rather than making the task fit the tool.

Once a study is complete, the result should be interpreted in the context of the original question. A negative HSAT in a complicated patient often just means the test was not the right instrument. A PSG that shows hypoventilation or central events may completely change the treatment plan. This is why ordering sleep studies is really an act of hypothesis testing, not shopping.

Practical selection logic

• Use HSAT when the adult patient has a high probability of uncomplicated moderate-to-severe OSA.

• Use PSG when you need sleep staging, arousal analysis, CO₂ monitoring, or better detection of central/hypoventilation patterns.

• Follow a negative or inadequate HSAT with PSG if suspicion remains.

• Consider split-night PSG only when the study can reasonably answer both diagnosis and titration.

Return to the Opening Case

The patient with obesity, chronic opioid use, severe insomnia, and possible hypoventilation should not have been sent for HSAT as the first test if the real concern was broader than uncomplicated OSA. The low REI is not a satisfying answer because the test never had a fair chance to detect hypoventilation, central apnea, or the effect of prolonged wakefulness on event estimation. The decisive clue is that the clinical question was never uncomplicated OSA in the first place.pmc.ncbi.nlm.nih+1

The best next step is PSG, ideally with CO₂ monitoring if hypoventilation is suspected. If the PSG shows sleep-related hypoventilation, central events, or severe sleep fragmentation, management can be tailored appropriately. The tempting alternative is to treat the low REI as a rule-out result. That is exactly how limited tests become expensive misunderstandings.

What the Attending Will Ask

1. When is HSAT appropriate? In selected adults with high suspicion for uncomplicated moderate-to-severe OSA and no major complicating conditions.pmc.ncbi.nlm.nih+1

1. When is PSG preferred? When there is significant cardiorespiratory disease, suspected hypoventilation, chronic opioid use, stroke history, severe insomnia, neuromuscular weakness, or concern for another sleep disorder.pmc.ncbi.nlm.nih+1

1. Why can HSAT underestimate severity? Because it often uses monitoring time rather than true sleep time and lacks full sleep staging and arousal analysis.

1. What does a technically inadequate HSAT mean? It means the study is incomplete, not that the patient does not have OSA.

1. Why does insomnia push you toward PSG? Because wakefulness can distort HSAT denominators and because PSG better characterizes sleep fragmentation.

1. Why is CO₂ monitoring important? Because hypoventilation is a ventilation problem, not just an oxygenation problem.pmc.ncbi.nlm.nih+1

1. Can a negative HSAT rule out OSA? No, especially when suspicion remains high or the patient is medically complicated.

1. What is the chief mistake with split-night studies? Assuming there will be enough time to answer both diagnosis and titration well.

Mistakes Smart Fellows Still Make

1. Ordering HSAT for suspected hypoventilation. This happens because the test is easy to obtain. It matters because the test cannot answer the relevant question. Avoid it by checking whether CO₂ monitoring is needed.

1. Treating a technically inadequate HSAT as negative. This happens because the report may still have a number on it. It matters because incomplete data can mislead. Avoid it by reading “technically inadequate” as “try again with a better test.”

1. Forgetting that HSAT may underestimate severity. This happens because the REI looks official. It matters because monitoring time is not the same as sleep time. Avoid it by considering insomnia and wakefulness.

1. Ordering a test without defining the question. This happens when clinicians jump straight to the device. It matters because the wrong test can miss the right diagnosis. Avoid it by asking what you need the study to show.

1. Assuming one negative night excludes OSA. This happens because we like clean answers. It matters because night-to-night variability and limited channels can produce false reassurance. Avoid it by following persistent suspicion with PSG.

1. Overusing split-night studies. This happens because efficiency is appealing. It matters because some nights are too complex or too short. Avoid it by selecting candidates carefully.

The Board Exam Is Trying to Trick You

1. The stem includes obesity, chronic opioids, insomnia, and possible hypoventilation, then asks for the next test. The trap is HSAT. The correct answer is PSG, often with CO₂ monitoring.

1. The question gives a low REI from HSAT and asks what it means. The trap is to call it a rule-out. The correct reasoning is that HSAT may have underestimated severity or missed the relevant physiology.

1. The patient has severe insomnia. The trap is to think HSAT is still fine because it is easier. The correct answer is that PSG is often preferred because sleep staging and true sleep time matter.

1. The stem asks about central apnea or hypoventilation. The trap is HSAT. The correct answer is PSG because the question is not uncomplicated OSA.

1. The question asks why CO₂ matters. The trap is to say “because oxygen is low.” The correct answer is that CO₂ monitoring detects hypoventilation, which oxygen alone may miss.

How to Explain This to a Patient

“We want to choose the test that can actually answer the question we have about your breathing during sleep. A home test can be very useful for uncomplicated sleep apnea, but it cannot fully assess sleep stages, arousals, carbon dioxide, or some complicated breathing problems. Because of your medications and symptoms, a lab study gives us a better chance of understanding what is really happening and choosing the right treatment.”

Practical Pearls

• Define the clinical question before choosing the test.

• HSAT is for selected uncomplicated adults with suspected OSA.

• PSG is preferred when central apnea, hypoventilation, insomnia, or other complexity is present.

• A low REI does not always mean low disease burden.

• Monitoring time is not the same as sleep time.

• A technically inadequate HSAT is not a negative study.

• CO₂ monitoring matters when ventilation is part of the question.

• Split-night studies work only when both diagnosis and titration can be adequately accomplished.

• The best test is the one that answers the question you actually have.

• Convenience should never outrun physiology.

The Bottom Line

• Start with the clinical question, not the device.

• HSAT is useful for selected uncomplicated adults with suspected OSA.

• PSG is better when the case is medically complicated or when staging, arousal analysis, or CO₂ monitoring is needed.pmc.ncbi.nlm.nih+1

• HSAT can underestimate severity because it often uses monitoring time rather than sleep time.

• A negative HSAT does not automatically exclude disease.

• A technically inadequate HSAT is not a valid rule-out.

• Chronic opioid use, severe insomnia, suspected hypoventilation, stroke, neuromuscular weakness, and significant cardiopulmonary disease push you toward PSG.pmc.ncbi.nlm.nih+1

• Split-night studies are useful only when they can answer both diagnosis and titration adequately.

• CO₂ monitoring is important when hypoventilation is suspected.

• The right test is the one that can see the thing you are worried about.

Question 1

A 49-year-old man with obesity, chronic opioid use, severe insomnia, and morning headaches is referred for evaluation of nocturnal breathing problems. Which test is most appropriate?

A. HSAT B. PSG, ideally with CO₂ monitoring C. No testing because the history is nonspecific D. Overnight oximetry alone E. Repeat the history in 6 months

Question 2

Which feature most strongly favors PSG over HSAT?

A. High suspicion for uncomplicated OSA in an otherwise healthy adult B. Need to determine whether sleep fragmentation is due to arousals and stage-specific disease C. A simple snoring complaint with no comorbidity D. Patient preference for a home-based test E. High BMI alone

Question 3

A technically adequate HSAT is negative in a patient with loud snoring, witnessed apneas, resistant hypertension, and severe daytime symptoms. What is the best next step?

A. Accept the HSAT as definitive B. Repeat the same HSAT indefinitely C. Obtain PSG D. Diagnose insomnia only E. Prescribe oxygen without further testing

Question 4

Why can HSAT underestimate OSA severity?

A. It always overestimates sleep time B. It uses monitoring time rather than true sleep time and lacks full staging C. It measures central apneas too well D. It is superior to PSG in all patients E. It eliminates night-to-night variability

Question 5

Which situation most strongly suggests the need for carbon-dioxide monitoring?

A. Uncomplicated snoring in a young adult B. Suspected obesity hypoventilation syndrome C. Seasonal allergies D. Mild insomnia without other symptoms E. Isolated dry mouth

Question 1

Correct answer: B. PSG, ideally with CO₂ monitoring.

Why it is correct: the combination of opioid use, severe insomnia, and possible hypoventilation makes this a medically complicated case where PSG is preferred.pmc.ncbi.nlm.nih+1 Why the others are wrong: A is too limited; C ignores the clinical concern; D cannot assess the relevant mechanisms; E delays the needed evaluation. Learning point: complicated physiology deserves a test that can see complicated physiology.

Question 2

Correct answer: B. Need to determine whether sleep fragmentation is due to arousals and stage-specific disease.

Why it is correct: PSG can stage sleep and detect arousals, which is useful when sleep fragmentation itself is part of the question.pmc.ncbi.nlm.nih+1 Why the others are wrong: A and C may be appropriate for HSAT; D is preference, not physiology; E alone does not automatically mandate PSG, though it may increase suspicion. Learning point: PSG is better when the question requires sleep architecture, not just respiratory signals.

Question 3

Correct answer: C. Obtain PSG.

Why it is correct: a negative HSAT does not rule out OSA when suspicion remains high, and PSG is the appropriate escalation.pmc.ncbi.nlm.nih+1 Why the others are wrong: A is false reassurance; B is inefficient and may repeat the same limitation; D ignores the respiratory symptoms; E treats without diagnosis. Learning point: persistent suspicion after a negative HSAT usually deserves PSG.

Question 4

Correct answer: B. It uses monitoring time rather than true sleep time and lacks full staging.

Why it is correct: this can dilute the event index, particularly in insomnia or fragmented sleep. Why the others are wrong: A is the opposite problem; C and E are not the main issue; D is false. Learning point: denominator problems matter.

Question 5

Correct answer: B. Suspected obesity hypoventilation syndrome.

Why it is correct: suspected hypoventilation requires assessment of ventilation, not just oxygenation.pmc.ncbi.nlm.nih+1 Why the others are wrong: A, C, D, and E are not classic reasons for CO₂ monitoring. Learning point: CO₂ monitoring is for ventilation questions.